Produkty 29913-71-1

CAS 29913-71-1 występuje w naszej ofercie pod nazwami: Licraside/ 99.85% (existing batch purity), Licraside, Licraside, 99.95%. Oferty producentów: TargetMol, Biosynth, Chemat, MedChemExpress. Dostępne opakowania: 1mg, 5mg, 10mg, 25mg, 50mg, 10mM/1mL, 10 mg.

Licraside/ 99.85% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 4
od 684,65
Zobacz produkt
Licraside
Biosynth, Chemat
  • opakowanie: 5mg, 1mg, 10mg, 25mg
  • Warianty: 9
od 462,80
Zobacz produkt
Licraside, 99.95%
MedChemExpress
  • opakowanie: 10mM/1mL, 10 mg
  • Warianty: 2
od 1750,04
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(E)-1-[4-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one (CAS 29913-71-1) to związek chemiczny o wzorze sumarycznym C26H30O13 i masie molowej 550.5 g/mol. Nazwa systematyczna IUPAC: (E)-1-[4-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one. InChIKey: NIZFPXZQERMCLE-KVFWHIKKSA-N.

Dane identyfikacyjne
Wzór sumarycznyC26H30O13
Masa molowa550.5 g/mol
Nazwa IUPAC(E)-1-[4-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
InChIKeyNIZFPXZQERMCLE-KVFWHIKKSA-N
SMILESC1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H](O[C@H]2OC3=CC(=C(C=C3)C(=O)/C=C/C4=CC=C(C=C4)O)O)CO)O)O)O)(CO)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Licuroside, Licraside, Licuraside, Licurazid, Liquirazide, licurazide, orb1308126
Izomery (ten sam wzór sumaryczny)
(2S)-2-[4-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-7-hydroxy-2,3-dihydrochromen-4-one C26H30O13
(2S)-7-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-[4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2,3-dihydrochromen-4-one C26H30O13
(4S,5E,6S)-4-(2-methoxy-2-oxoethyl)-5-[2-[(E)-3-phenylprop-2-enoyl]oxyethylidene]-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4H-pyran-3-carboxylic acid C26H30O13
methyl (1S,4aS,5R,7aS)-7-(hydroxymethyl)-5-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]oxy-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate C26H30O13
(E)-3-[4-[(2S,3R,4S,5S,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-1-(2,4-dihydroxyphenyl)prop-2-en-1-one C26H30O13